Ronit Capital LLP Mesoblast LTD Transaction History

Ronit Capital LLP

  • $74.3 Million
  • Q3 2022

A detailed history of Ronit Capital LLP transactions in Mesoblast LTD stock. As of the latest transaction made, Ronit Capital LLP holds 150,000 shares of MESO stock, worth $3.16 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
150,000
Holding current value
$3.16 Million
% of portfolio
0.51%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022
BUY
$0.48 - $3.48 $72,000 - $522,000
150,000 New
150,000 $382,000

Others Institutions Holding MESO

# of Institutions
3
Shares Held
151K
Call Options Held
0
Put Options Held
0
View Full List

About MESOBLAST LTD

MESO Quotes by TradingView
  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $3.1B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Ronit Capital LLP Portfolio

Follow Ronit Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronit Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Ronit Capital LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email